Literature DB >> 1640283

Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children.

K L Armstrong1, R W James, D J Dawson, P W Francis, B Masters.   

Abstract

We describe five apparently immunologically normal children with infection caused by Mycobacterium haemophilum and resulting in perihilar or cervical lymphadenitis. Clinical distinction from Mycobacterium tuberculosis infection could be made by culture only, because differential Mantoux test results suggested tuberculosis. Treatment of these children involved chemotherapy or surgery or both, and outcome in all cases has been excellent. We believe that M. haemophilum should be added to the list of non-tuberculosis mycobacteria known to cause lymphadenitis in otherwise healthy children.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640283     DOI: 10.1016/s0022-3476(05)81188-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy.

Authors:  Z Samra; L Kaufmann; A Zeharia; S Ashkenazi; J Amir; J Bahar; U Reischl; L Naumann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 2.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient.

Authors:  Theobald J C Minani; Michael A Saubolle; Edwin Yu; Zdenek Sussland
Journal:  J Clin Microbiol       Date:  2010-05-19       Impact factor: 5.948

Review 4.  Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.

Authors:  M A Saubolle; T E Kiehn; M H White; M F Rudinsky; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

5.  Lesser known mycobacteria.

Authors:  B Watt
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

Review 6.  Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections.

Authors:  Jerome A Lindeboom; Lesla E S Bruijnesteijn van Coppenraet; Dick van Soolingen; Jan M Prins; Eduard J Kuijper
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

7.  Novel mycobacterium related to Mycobacterium triplex as a cause of cervical lymphadenitis.

Authors:  R Hazra; M M Floyd; A Sloutsky; R N Husson
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

Review 8.  Mycobacterium haemophilum: an emerging pathogen.

Authors:  T E Kiehn; M White
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

9.  Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B).

Authors:  L J Fischer; F D Quinn; E H White; C H King
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Mycobacterium haemophilum and lymphadenitis in children.

Authors:  Lesla E S Bruijnesteijn van Coppenraet; Edward J Kuijper; Jerome A Lindeboom; Jan M Prins; Eric C J Claas
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.